XML 19 R6.htm IDEA: XBRL DOCUMENT v3.3.0.814
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
 9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Cash flows from operating activities:    
Income (loss) for the period $ (4,297,307) $ 3,755,438
Adjustments to reconcile income (loss) for the period to net cash used in operating activities:    
Depreciation 29,709 26,091
Stock-based compensation 15,675 19,854
Change in the fair value of Warrants with down-round protection (119,148) (6,344,340)
Linkage difference on principal of loans from stockholders (1,384) $ 666
Loss on partial extinguishment of Series A Preferred Stock and Series A Warrants 1,284,354
Changes in assets and liabilities:    
Decrease (increase) in accounts receivable 1,251 $ (14,319)
Increase in inventory (180,144) (139,308)
Increase in other current assets (135,485) (16,354)
Increase in accounts payable 363,639 151,892
Increase (decrease) in other current liabilities (68,374) 140,541
Net cash used in operating activities (3,107,214) (2,419,839)
Cash flows from investing activities:    
Increase in funds in respect of employee rights upon retirement (24,279) (28,058)
Purchase of property and equipment (94,714) (51,485)
Net cash used in investment activities (118,993) (79,543)
Cash flows from financing activities    
Cash dividend on Series A Preferred Stock $ (52,361) (277,852)
Proceeds allocated to convertible Preferred Stock, net of cash issuance expenses 2,435,844
Proceeds allocated to Series B-1 and Series B-2 warrants, net of cash issuance expenses $ 2,384,429
Repayment of loan from stockholders $ (439,939)
Net cash provided by (used in) financing activities (492,300) $ 4,542,421
Effect of exchange rate changes on cash and cash equivalents (4,195) (40,970)
Increase (decrease) in cash and cash equivalents (3,722,702) 2,002,069
Cash and cash equivalents at beginning of the period 5,827,560 2,385,911
Cash and cash equivalents at end of the period $ 2,104,858 $ 4,387,980